Abstracted Scientific Content

Published in:
Volume 7 / Year 2018 / Issue 1

Barriers to generics policy reform: a US case study

Page: 48

A recent comparison of generic drug markets [1] explores the history of generics substitution and bioequivalence policies in the US, in order to understand the barriers to implementing reform of generic drug policies.… Read More »

Go Back Print